| Maduka Nnadozie, | |
|
2015 Pacific Ave, Atlantic City, NJ 08401-6726 | |
| (609) 441-8194 | |
| Not Available |
| Full Name | Maduka Nnadozie |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 2015 Pacific Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356911945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 1356911945 (New Jersey) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maduka Nnadozie, 2015 Pacific Ave, Atlantic City, NJ 08401-6726 Ph: (609) 441-8194 | Maduka Nnadozie, 2015 Pacific Ave, Atlantic City, NJ 08401-6726 Ph: (609) 441-8194 |
News Archive
Pioneering research by a North East of England scientist could lead to a cure for some of the most deadly antibiotic-resistant diseases.
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the European Medicines Agency (EMA) has recommended 4SC's anti-cancer compound resminostat for designation as orphan medicinal product for the treatment of Hodgkin's Lymphoma (HL), a cancer of the lymphatic system.
Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of the benefits of endovascular techniques grows and physician training improves.
On the third anniversary of the establishment of federal support for stem cell research, the Juvenile Diabetes Research Foundation, released a new scientific white paper today that outlines why the current policy must be expanded.
› Verified 5 days ago